|
||||
Public Act 095-0282 |
||||
| ||||
| ||||
AN ACT concerning health.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 5. The Mental Health and Developmental | ||||
Disabilities Administrative Act is amended by adding Section | ||||
10.5 as follows: | ||||
(20 ILCS 1705/10.5 new) | ||||
Sec. 10.5. Prevention and control of Multidrug-Resistant | ||||
Organisms. The Department, in consultation with the Department | ||||
of Public Health, shall adopt rules that may require one or | ||||
more of the facilities described in Section 4 of this Act to | ||||
implement comprehensive interventions to prevent and control | ||||
multidrug-resistant organisms (MDROs), including | ||||
methicillin-resistant Staphylococcus aureus (MRSA), | ||||
vancomycin-resistant enterococci (VRE), and certain | ||||
gram-negative bacilli (GNB), pursuant to updated prevention | ||||
and control interventions recommended by the U.S. Centers for | ||||
Disease Control and Prevention. The Department shall also | ||||
require facilities to submit reports to the Department that | ||||
contain substantially the same information contained in the | ||||
related infection reports required to be submitted by hospitals | ||||
to the Department of Public Health under Section 25 of the | ||||
Hospital Report Card Act. The Department shall provide that |
information to the Department of Public Health upon the | ||
Department of Public Health's request. | ||
Section 10. The Department of Public Health Powers and | ||
Duties Law of the
Civil Administrative Code of Illinois is | ||
amended by adding Section 2310-312 as follows: | ||
(20 ILCS 2310/2310-312 new) | ||
Sec. 2310-312. Multidrug-Resistant Organisms. The | ||
Department shall perform the following functions in relation to | ||
the prevention and control of Multidrug-Resistant Organisms | ||
(MDROs), including methicillin-resistant Staphylococcus aureus | ||
(MRSA), vancomycin-resistant (VRE) and certain gram-negative | ||
bacilli (GNB), as these terms are referenced by the United | ||
States Centers for Disease Control and Prevention: | ||
(1) Except with regard to hospitals, for which | ||
administrative rules shall be adopted in accordance with | ||
Section 6.23 of the Hospital Licensing Act and Section 7 of | ||
the University of Illinois Hospital Act, the Department | ||
shall adopt administrative rules for health care | ||
facilities subject to licensure, certification, | ||
registration, or other regulation by the Department that | ||
may require one or more types of those facilities to (i) | ||
perform an annual infection control risk assessment, (ii) | ||
develop infection control policies for MDROs that are based | ||
on this assessment and incorporate, as appropriate, |
updated recommendations of the U.S. Centers for Disease | ||
Control and Prevention for the prevention and control of | ||
MDROs, and (iii) enforce hand hygiene requirements. | ||
(2) The Department shall: | ||
(A) publicize guidelines for reducing the | ||
incidence of MDROs to health care providers, health | ||
care facilities, public health departments, prisons, | ||
jails, and the general public; and | ||
(B) provide periodic reports and updates to public | ||
officials, health professionals, and the general | ||
public statewide regarding new developments or | ||
procedures concerning prevention and management of | ||
infections due to MDROs. | ||
(3) The Department shall publish a yearly report | ||
regarding MRSA and Clostridium difficile infections based | ||
on the Hospital Discharge Dataset. The Department is | ||
authorized to require hospitals, based on guidelines | ||
developed by the National Center for Health Statistics, | ||
after October 1, 2007, to submit data to the Department | ||
that is coded as "present on admission" and "occurred | ||
during the stay". | ||
(4) Reporting to the Department under the Hospital | ||
Report Card Act shall include organisms, including but not | ||
limited to MRSA, that are responsible for central venous | ||
catheter-associated bloodstream infections and | ||
ventilator-associated pneumonia in designated hospital |
units. | ||
(5) The Department shall implement surveillance for | ||
designated cases of community associated MRSA infections | ||
for a period of at least 3 years, beginning on or before | ||
January 1, 2008. | ||
Section 15. The University of Illinois Hospital Act is | ||
amended by adding Section 7 as follows: | ||
(110 ILCS 330/7 new) | ||
Sec. 7. Prevention and control for Multidrug-Resistant | ||
Organisms. The University of Illinois Hospital shall develop | ||
and implement comprehensive interventions to prevent and | ||
control multidrug-resistant organisms (MDROs), including | ||
methicillin-resistant Staphylococcus aureus (MRSA), | ||
vancomycin-resistant enterococci (VRE), and certain | ||
gram-negative bacilli (GNB), that take into consideration | ||
guidelines of the U.S. Centers for Disease Control and | ||
Prevention for the management of MDROs in healthcare settings. | ||
The Department of Public Health shall adopt administrative | ||
rules that require the University of Illinois Hospital to | ||
perform an annual facility-wide infection control risk | ||
assessment and enforce hand hygiene and contact precaution | ||
requirements. | ||
Section 20. The Hospital Licensing Act is amended by adding |
Section 6.23 as follows: | ||
(210 ILCS 85/6.23 new) | ||
Sec. 6.23. Prevention and control of Multidrug-Resistant | ||
Organisms. Each hospital shall develop and implement | ||
comprehensive interventions to prevent and control | ||
multidrug-resistant organisms (MDROs), including | ||
methicillin-resistant Staphylococcus aureus (MRSA), | ||
vancomycin-resistant enterococci (VRE), and certain | ||
gram-negative bacilli (GNB), that take into consideration | ||
guidelines of the U.S. Centers for Disease Control and | ||
Prevention for the management of MDROs in healthcare settings. | ||
The Department shall adopt administrative rules that require | ||
hospitals to perform an annual facility-wide infection control | ||
risk assessment and enforce hand hygiene and contact precaution | ||
requirements. | ||
Section 25. The Hospital Report Card Act is amended by | ||
changing Section 25 as follows:
| ||
(210 ILCS 86/25)
| ||
Sec. 25. Hospital reports.
| ||
(a) Individual hospitals shall prepare a quarterly report | ||
including all of
the
following:
| ||
(1) Nursing hours per patient day, average daily | ||
census, and average daily
hours worked
for each clinical |
service area.
| ||
(2) Infection-related measures for the facility for | ||
the specific clinical
procedures
and devices determined by | ||
the Department by rule under 2 or more of the following | ||
categories:
| ||
(A) Surgical procedure outcome measures.
| ||
(B) Surgical procedure infection control process | ||
measures.
| ||
(C)
Outcome or process measures related to | ||
ventilator-associated pneumonia.
| ||
(D) Central vascular catheter-related bloodstream | ||
infection rates in designated critical care units.
| ||
(3) Information required under paragraph (4) of | ||
Section 2310-312 of the Department of Public Health Powers | ||
and Duties Law of the
Civil Administrative Code of | ||
Illinois.
| ||
The infection-related measures developed by the Department | ||
shall be based upon measures and methods developed by the | ||
Centers for Disease Control and Prevention, the Centers for | ||
Medicare and Medicaid Services, the Agency for Healthcare | ||
Research and Quality, the Joint Commission on Accreditation of | ||
Healthcare Organizations, or the National Quality Forum. | ||
The Department shall include interpretive guidelines for | ||
infection-related indicators and, when available, shall | ||
include relevant benchmark information published by national | ||
organizations.
|
(b) Individual hospitals shall prepare annual reports | ||
including vacancy and
turnover rates
for licensed nurses per | ||
clinical service area.
| ||
(c) None of the information the Department discloses to the | ||
public may be
made
available
in any form or fashion unless the | ||
information has been reviewed, adjusted, and
validated
| ||
according to the following process:
| ||
(1) The Department shall organize an advisory | ||
committee, including
representatives
from the Department, | ||
public and private hospitals, direct care nursing staff,
| ||
physicians,
academic researchers, consumers, health | ||
insurance companies, organized labor,
and
organizations | ||
representing hospitals and physicians. The advisory | ||
committee
must be
meaningfully involved in the development | ||
of all aspects of the Department's
methodology
for | ||
collecting, analyzing, and disclosing the information | ||
collected under this
Act, including
collection methods, | ||
formatting, and methods and means for release and
| ||
dissemination.
| ||
(2) The entire methodology for collecting and | ||
analyzing the data shall be
disclosed
to all
relevant | ||
organizations and to all hospitals that are the subject of | ||
any
information to be made
available to the public before | ||
any public disclosure of such information.
| ||
(3) Data collection and analytical methodologies shall | ||
be used that meet
accepted
standards of validity and |
reliability before any information is made available
to the | ||
public.
| ||
(4) The limitations of the data sources and analytic | ||
methodologies used to
develop
comparative hospital | ||
information shall be clearly identified and acknowledged,
| ||
including but not
limited to the appropriate and | ||
inappropriate uses of the data.
| ||
(5) To the greatest extent possible, comparative | ||
hospital information
initiatives shall
use standard-based | ||
norms derived from widely accepted provider-developed
| ||
practice
guidelines.
| ||
(6) Comparative hospital information and other | ||
information that the
Department
has
compiled regarding | ||
hospitals shall be shared with the hospitals under review
| ||
prior to
public
dissemination of such information and these | ||
hospitals have 30 days to make
corrections and
to add | ||
helpful explanatory comments about the information before | ||
the
publication.
| ||
(7) Comparisons among hospitals shall adjust for | ||
patient case mix and
other
relevant
risk factors and | ||
control for provider peer groups, when appropriate.
| ||
(8) Effective safeguards to protect against the | ||
unauthorized use or
disclosure
of
hospital information | ||
shall be developed and implemented.
| ||
(9) Effective safeguards to protect against the | ||
dissemination of
inconsistent,
incomplete, invalid, |
inaccurate, or subjective hospital data shall be developed
| ||
and
implemented.
| ||
(10) The quality and accuracy of hospital information | ||
reported under this
Act
and its
data collection, analysis, | ||
and dissemination methodologies shall be evaluated
| ||
regularly.
| ||
(11) Only the most basic identifying information from | ||
mandatory reports
shall be
used, and
information | ||
identifying a patient, employee, or licensed professional
| ||
shall not be released.
None of the information the | ||
Department discloses to the public under this Act
may be | ||
used to
establish a standard of care in a private civil | ||
action.
| ||
(d) Quarterly reports shall be submitted, in a format set | ||
forth in rules
adopted
by the
Department, to the Department by | ||
April 30, July 31, October 31, and January 31
each year
for the | ||
previous quarter. Data in quarterly reports must cover a period | ||
ending
not earlier than
one month prior to submission of the | ||
report. Annual reports shall be submitted
by December
31 in a | ||
format set forth in rules adopted by the Department to the | ||
Department.
All reports
shall be made available to the public | ||
on-site and through the Department.
| ||
(e) If the hospital is a division or subsidiary of another | ||
entity that owns
or
operates other
hospitals or related | ||
organizations, the annual public disclosure report shall
be for | ||
the specific
division or subsidiary and not for the other |
entity.
| ||
(f) The Department shall disclose information under this | ||
Section in
accordance with provisions for inspection and | ||
copying of public records
required by the Freedom of
| ||
Information Act provided that such information satisfies the | ||
provisions of
subsection (c) of this Section.
| ||
(g) Notwithstanding any other provision of law, under no | ||
circumstances shall
the
Department disclose information | ||
obtained from a hospital that is confidential
under Part 21
of | ||
Article 8 of the Code of Civil Procedure.
| ||
(h) No hospital report or Department disclosure may contain | ||
information
identifying a patient, employee, or licensed | ||
professional.
| ||
(Source: P.A. 93-563, eff. 1-1-04; 94-275, eff. 7-19-05.)
| ||
Section 99. Effective date. This Act takes effect upon | ||
becoming law.
|